Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Efficacy, Safety and Tolerability of Stratamark® (Innovative Self-drying Silicone Gel) in the Treatment and Prevention of Striae Distensae

NCT03377231 is registered in ClinicalTrials.gov with Stratpharma AG as lead sponsor.

NCT NCT03377231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Efficacy, Safety and Tolerability of Stratamark® (Innovative Self-drying Silicone Gel) in the Treatment and Prevention of Striae Distensae
Lead sponsor
Stratpharma AG
Phase
Phase 4
Overall status
Completed
Start date
July 11, 2013
Completion date
May 16, 2016
Enrollment
272 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stretch mark